Skip to main content

Crinetics Pharmaceuticals, Inc. insider trading

CRNXNASDAQ
$84.950.00 (0.00%)Delayed · as of Sep 2, 2026

“Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.” — Peter Lynch

Insider Trading vs Stock Price

Insider Trading vs Stock Price data

Showing the 1Y range: Oct 2, 2025 to Sep 2, 2026. Price (+104.6%). 0 insider transactions plotted in this window as 0 markers; nearby trades of the same kind are grouped.

Transactions plotted on the price chart
DateCategoryPersonRoleActionAmountChange in holding
Open market purchase
Open market sell
Marker size reflects transaction size.

Net dollar flow · Buy / Sell balance

Premium
Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Unlock quarterly net flow

Key players

  • WWWendall WierengaDirector0.1095%of company
  • MWMarc WilsonCFO0.1052%of company
  • JEJeff E. KnightChief Dev. & Operating Officer0.0993%of company
  • DPDana PizzutiChief Med and Dev Officer0.063%of company
  • RSRichard Scott StruthersPresident & CEO0.00%of company
  • MKMatthew K. FustDirector0.00%of company
  • WNWeston NicholsDirector0.00%of company
  • SFStephen F. BetzChief Scientific Officer0.00%of company
  • WWWendell WierengaDirector0.00%of company
  • SOStephanie OkeyDirector0.00%of company

AI Activity Analysis

Premium
Coming soonAI reads of insider activity will appear here for Premium accounts.

Insider activity

Fromto
CompanyInsider / roleActionΔOwnAvg priceAmount
CRNXCoelho Rogerio VivaldiDirectorOpen market sell$120K-13.5%$40.00$120KJul 2, 2026Jul 7, 2026
CRNXStephanie OkeyDirectorOpen market sell$22K-8.7%$36.22$22KJun 17, 2026Jun 18, 2026
CRNXStephanie OkeyDirectorOpen market sell$224K-47.3%$35.62$224KJun 17, 2026Jun 18, 2026
CRNXJeff E. KnightChief Operating OfficerOpen market sell$150K-3.4%$37.77$150KMar 16, 2026Mar 18, 2026
CRNXJeff E. KnightChief Operating OfficerOpen market sell$221K-4.9%$37.11$221KMar 16, 2026Mar 18, 2026
CRNXStephen F. BetzChief Scientific OfficerOpen market sell$160K-3.0%$37.77$160KMar 16, 2026Mar 18, 2026
CRNXStephen F. BetzChief Scientific OfficerOpen market sell$236K-4.3%$37.11$236KMar 16, 2026Mar 18, 2026
CRNXRichard Scott StruthersPresident & CEOOpen market sell$332K-0.6%$37.77$332KMar 16, 2026Mar 18, 2026
CRNXRichard Scott StruthersPresident & CEOOpen market sell$490K-0.9%$37.11$490KMar 16, 2026Mar 18, 2026
CRNXCoelho Rogerio VivaldiDirectorOpen market sell$19.2K-3.1%$36.77$19.2KMar 12, 2026Mar 13, 2026
CRNXCoelho Rogerio VivaldiDirectorOpen market sell$162K-21.0%$36.08$162KMar 12, 2026Mar 13, 2026
CRNXStephanie OkeyDirectorOpen market sell$119K-18.4%$39.67$119KMar 3, 2026Mar 4, 2026
CRNXTobin SchilkeChief Financial OfficerOpen market sell$266K-7.9%$39.67$266KMar 3, 2026Mar 4, 2026
End of history · 13 transactions
SpoorBase

Not investment advice. We make every effort to keep the information on SpoorBase accurate, but errors may occur. SpoorBase does not guarantee the accuracy or completeness of any data, and any use of the information is at the user’s sole responsibility. Valuation multiples are calculated by SpoorBase and may contain errors. See Disclosures. © 2026 SpoorBase. All rights reserved.